platinum 789Final analysis of the phase III KEYNOTE-789 trial evaluating pemetrexedplatinum chemotherapy with or without pembrolizumab in TKI-resistant, EGFR-mutated, metastaticSee relevant content for platinum789i.shop. Please turn off your ad blocker.